Advertisement

Topics

China YCT International Group, Inc. Company Profile

01:07 EDT 30th June 2016 | BioPortfolio

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use chemical products, ginkgo glycoside products and biological medicines.


News Articles [2362 Associated News Articles listed on BioPortfolio]

Wanda Group Invests $2.3 Billion to Build Three China Hospitals

Dalian Wanda Group, a China conglomerate, announced a $2.3 billion investment in three China hospitals. The hospitals will be managed by Britain's International Hospitals Group, assuring they will con...

Bain Capital Buys Controlling Interest in China Hospital Chain for $150 Million

Bain Capital of the US is paying $150 million for a majority stake in Asia Pacific Medical Group, a collection of five hospitals and several clinics in China and southeast Asia. The facilities serve b...

China's big investment to fix environmental wrongs shows both people, nature can win

China's massive investment to mitigate the ecosystem bust that has come in the wake of the nation's economic boom is paying off. An international group of scientists finds both humans and nature can t...

Zizhu gets China rights to Uni-Bio's eye drug

Uni-Bio Science Group Ltd. (HKSE:690) said it granted exclusive commercialization rights in China to ophthalmology treatment GeneSoft to the China Resources Zizhu Pharmaceutical Co. Ltd. subsidiary of...

China A Key Driver Of Roche’s International Growth

China market remains strong in sales of both pharma and diagnostics for Roche under expectation, with strategic approval and additional reimbursement of several oncology products in the country. Durin...

Huya Bridges China's Novel Drugs With Overseas Markets

China is not a place one usually looks to for innovation, especially over a decade ago. When Mireille Gillings, founder and chairman of Huya Bioscience International first visited China in 2004, she s...

Genesis Rehab Services and Apollo Education Group Expand Into China

KENNETT SQUARE, PA -- Genesis Rehab Services announced Jan. 11 it has joined with Apollo Education Group Inc. to develop scalable rehabilitation therapy training programs in China. The programs ar...

China's Richest Man Wang Jianlin Targets Growth In Healthcare With $2.3B Investment

Wanda Group, controlled by China’s richest man Wang Jianlin, said today it will team up with International Hospitals Groupand invest 15 billion yuan, or $2.3 billion, in three hospitals in Shanghai,...

PubMed Articles [5590 Associated PubMed Articles listed on BioPortfolio]

Which types of income matter most for well-being in China: Absolute, relative or income aspirations?

China has experienced remarkable economic growth, but that has not been associated with increases in individual well-being, implying that well-being may not be sensitive to increases in absolute incom...

Income-related health inequality of migrant workers in China and its decomposition: An analysis based on the 2012 China Labor-force Dynamics Survey data.

Although migrant workers are a vulnerable group in China, they demonstrably contribute to the country's economic growth and prosperity. This study aimed to describe and assess the inequality of migran...

Peer Support Training Improved the Glycemic Control, Insulin Management, and Diabetic Behaviors of Patients with Type 2 Diabetes in Rural Communities of Central China: A Randomized Controlled Trial.

BACKGROUND The efficacy of peer support in Chinese diabetes patients is still uncertain. The purpose of this study was to observe the effects of a peer support program on the outcomes of patients with...

Critical appraisal of international guidelines on chronic heart failure: Can China AGREE?

Nursing Practice Guidelines in China do Need Reform: A Critical Appraisal Using the AGREEII Instrument.

An increasing number of nursing practice guidelines (NPGs) of varying methodological and reporting quality have been issued and published in international journals. Currently the quality of NPGs in ma...

Clinical Trials [3195 Associated Clinical Trials listed on BioPortfolio]

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require...

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

This clinical trial is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial comparing one dose of linaclotide to placebo. Approximately 800 pat...

International Programs Collaborative Studies Coordinating Center

To continue the work of the Collaborative Studies Coordinating Center (CSCC) on international studies in cardiopulmonary disease epidemiology. The work was being performed under bilateral...

Practice of Mechanical Ventilation in Patients With Severe Brain Injury in China

The mechanical ventilation strategy has changed over years worldwide. Several international researches have been conducted to study the association of the use of mechanical ventilation wit...

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

This study is part of International Vaccine Institute (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries...

Companies [3325 Associated Companies listed on BioPortfolio]

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under...

China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic...

China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily engaged in the development, production and sales of health...

eChinaChem

eChinaChem, Inc., the China subsidiary of Pacific Genuity, Inc. (San Carlos, California), provides an integrated end-to-end solution for international chemical trading with China. Our company offers ...

Medichem International

Medichem International Trading Company founded in 1993 as a pharmaceutical sourcing company in Hong Kong. In 1998 two chemical factories in China jointly invested to establish the Medichem China Group...

More Information about "China YCT International Group, Inc." on BioPortfolio

We have published hundreds of China YCT International Group, Inc. news stories on BioPortfolio along with dozens of China YCT International Group, Inc. Clinical Trials and PubMed Articles about China YCT International Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China YCT International Group, Inc. Companies in our database. You can also find out about relevant China YCT International Group, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record